Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

118.92
Delayed Data
As of Apr 20
 -0.08 / -0.07%
Today’s Change
13.09
Today|||52-Week Range
154.75
+29.56%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 175.00, with a high estimate of 210.00 and a low estimate of 150.00. The median estimate represents a +47.16% increase from the last price of 118.92.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.76
Sales
$0.00
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.81%
 
 
 
 
 
 
Growthannually -43.57%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.